Literature DB >> 16940394

Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis.

G Chironi1, C Pagnoux, A Simon, M Pasquinelli-Balice, M Del-Pino, J Gariepy, L Guillevin.   

Abstract

BACKGROUND AND
OBJECTIVE: Although changes in smaller vessels is the hallmark of medium-sized and small-vessel vasculitis, it has been suggested that large arteries of such patients may also be affected by the early atherosclerotic process because of coexisting risk factors or systemic inflammation. This study aimed to bring additional arguments supporting this hypothesis. DESIGN, SETTING AND PATIENTS: 50 consecutive patients with primary systemic necrotising vasculitis and 100 controls matched for age and sex underwent ultrasonic detection of plaque in three peripheral vessels (carotid and femoral arteries and abdominal aorta). Cardiovascular risk factors and inflammation (C reactive protein (CRP)) were concomitantly measured in all participants, and diagnosis of high-risk status was defined by the presence of known history of cardiovascular disease, type 2 diabetes or 10-year-Framingham Risk Score > or =20%.
RESULTS: Patients had higher frequency of plaque than controls in the carotid arteries (p<0.05), in the aorta (p<0.01) and in the three vessels examined (p<0.001), and adjustment for high-risk status did not confound such difference in the aorta and in the three vessels. In the overall population of patients and controls, vasculitis was associated with a higher frequency of three-vessel plaques (p<0.05), independently of high-risk status and CRP. In patients, the higher frequency of three-vessel plaques was associated with high-risk status (p<0.05) but not with CRP, or disease and treatment characteristics.
CONCLUSIONS: Small-vessel vasculitis is associated with more frequent subclinical atherosclerosis, especially extended to multiple peripheral vessels, and such association is not entirely explained by cardiovascular risk factors and systemic inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16940394      PMCID: PMC1861337          DOI: 10.1136/hrt.2006.088443

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  14 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 2.  Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk.

Authors:  Alain Simon; Jérôme Gariepy; Gilles Chironi; Jean-Louis Megnien; Jaime Levenson
Journal:  J Hypertens       Date:  2002-02       Impact factor: 4.844

3.  Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes.

Authors:  A Simon; J Gariépy; D Moyse; J Levenson
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

4.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

5.  Relationship of circulating biomarkers of inflammation and hemostasis with preclinical atherosclerotic burden in nonsmoking hypercholesterolemic men.

Authors:  Gilles Chironi; Christine Dosquet; Muriel Del-Pino; Nicolas Denarie; Jean-Louis Megnien; Ludovic Drouet; Claire Bal dit Sollier; Jaime Levenson; Alain Simon
Journal:  Am J Hypertens       Date:  2006-10       Impact factor: 2.689

Review 6.  Small-vessel vasculitis.

Authors:  J C Jennette; R J Falk
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

7.  Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?

Authors:  K Raza; J Thambyrajah; J N Townend; A R Exley; C Hortas; A Filer; D M Carruthers; P A Bacon
Journal:  Circulation       Date:  2000-09-26       Impact factor: 29.690

8.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

9.  Extracoronary atherosclerotic plaque at multiple sites and total coronary calcification deposit in asymptomatic men. Association with coronary risk profile.

Authors:  A Simon; P Giral; J Levenson
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

10.  Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation.

Authors:  A D Booth; D R W Jayne; R K Kharbanda; C M McEniery; I S Mackenzie; J Brown; I B Wilkinson
Journal:  Circulation       Date:  2004-03-22       Impact factor: 29.690

View more
  12 in total

1.  The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study.

Authors:  Rula A Hajj-Ali; Jennifer Major; Carol Langford; Garry S Hoffman; Tiffany Clark; Li Zhang; Zhiyuan Sun; Roy L Silverstein
Journal:  Transl Res       Date:  2015-04-13       Impact factor: 7.012

2.  Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare.

Authors:  Emmanuel Ribeiro; Thomas Cressend; Pierre Duffau; Marieke Grenouillet-Delacre; Marie Rouanet-Larivière; Anne Vital; Maïté Longy-Boursier; Patrick Mercié
Journal:  Case Rep Med       Date:  2010-03-14

3.  Perimyocarditis and myocardial infarction: A rare manifestation of Churg-Strauss syndrome.

Authors:  Christoph Gräni; Thomas Langenegger; Anja Fäh; David Kurz; Rainer Zbinden; David Ramsay
Journal:  Exp Clin Cardiol       Date:  2012

4.  Carotid artery intima-media thickness, heat shock proteins and oxidized LDL autoantibodies in systemic necrotizing vasculitis.

Authors:  Yaniv Sherer; Christian Pagnoux; Gilles Chironi; Alain Simon; Loïc Guillevin; Luc Mouthon; Boris Gilburd; Yehuda Shoenfeld
Journal:  Rheumatol Int       Date:  2008-04-29       Impact factor: 2.631

Review 5.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

Review 6.  Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.

Authors:  J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

7.  Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis.

Authors:  Junichi Hirahashi; Kimito Kawahata; Makoto Arita; Ryo Iwamoto; Keiichi Hishikawa; Mie Honda; Yoshifumi Hamasaki; Mototsugu Tanaka; Koshu Okubo; Miho Kurosawa; Osamu Takase; Masanori Nakakuki; Kan Saiga; Kazuo Suzuki; Shoji Kawachi; Akihiro Tojo; George Seki; Takeshi Marumo; Matsuhiko Hayashi; Toshiro Fujita
Journal:  Sci Rep       Date:  2014-09-18       Impact factor: 4.379

8.  Endothelial dysfunction in patients with granulomatosis with polyangiitis: a case-control study.

Authors:  Renata Pacholczak; Stanisława Bazan-Socha; Teresa Iwaniec; Lech Zaręba; Stan Kielczewski; Jerzy A Walocha; Jacek Musiał; Jerzy Dropiński
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

9.  Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications.

Authors:  Maria F Lopes-Virella; Rickey E Carter; Gregory E Gilbert; Richard L Klein; Miran Jaffa; Alicia J Jenkins; Timothy J Lyons; W Timothy Garvey; Gabriel Virella
Journal:  Diabetes Care       Date:  2008-07-15       Impact factor: 17.152

10.  Type-I interferons in atherosclerosis.

Authors:  Hung-Jen Chen; Sander W Tas; Menno P J de Winther
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.